Genetics & Applications (Jun 2020)

Hematological parameters in patients with rheumatoid arthritis and gene variants HLA-DRB1*04 and HLA-DRB1*03

  • Biljana Klimenta,
  • Hilada Nefić,
  • Nenad Prodanović,
  • Fatima Hukić,
  • Aner Mešić

DOI
https://doi.org/10.31383/ga.vol4iss1pp30-37
Journal volume & issue
Vol. 4, no. 1

Abstract

Read online

Rheumatoid arthritis is a polygenic disease of unknown etiology, occurs worldwide in both developed and underdeveloped countries and involves all races. The aim of this study is to determine the correlation between hematological parameters (DBC and ESR) and biomarkers of inflammation (CRP) in patients with RA predisposing gene variants HLA-DRB1*04orHLA-DRB1*03. This study analyzed the results of hematological and biochemical parameters of 33 patients diagnosed with RA, carriers ofgene variants of HLA-DRB1*04 or HLA-DRB1*03, and 33 subjects of control group non-carriers for HLA-DRB1*04 or HLA-DRB1*03. All hematological parameters (DBC) were analyzed on a Beckman Coulter DxH 800 hematology counter. The erythrocyte sedimentation rate was expressed in mm/h. The CRP biochemical test was performed on a Cobas c311 automatic analyzer. In groupof RA patients carriers of HLA-DRB1*04orHLA-DRB1*03 gene variants, the values of HGB and HCTwere significantlylower(p < 0.05) while the values of RDW, RDW-SD, MO, BA, MO#, BA#, ESR and CRPwere statistically increased(p < 0.05) from the control group without these variants.

Keywords